Pierrel Research USA Launches Orabloc™ A New Purer Articaine

From Medical News Today Pierrel Research USA, Inc., a subsidiary of Pierrel SpA, the Italian-based, global pharmaceutical services company, announces the US launch of Orabloc™ (Articaine hydrochloride 4% with epinephrine 1:100,000 and Articaine hydrochloride 4% with epinephrine 1:200,000). Orabloc is…